the Image

Open Cancer Clinical Trials

The University of Chicago Medicine Comprehensive Cancer Center is leading the way in biomedical discoveries that will help physicians fight cancer more effectively. Our dedicated researchers and clinicians are conducting clinical trials in phases I, II, III and IV, leading to the development of new and better treatments. If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Kidney/ Renal Cancer Clinical Trials
Interventional only

Phase III
Study No PI Title
IRB16-1354 Stadler, Walter A Phase III, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study Of Atezolizumab (Anti-PD-L1 Antibody) As Adjuvant Therapy In Patients With Renal Cell Carcinoma At High Risk Of Developing Metastasis Following Nephrectomy Details
Phase II
Study No PI Title
IRB18-0605 Sweis, Randy A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors Details
IRB18-0249 Stadler, Walter A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing CB-839 in Combination with Cabozantinib (CB-Cabo) vs. Placebo with Cabozantinib (Pbo-Cabo) in Patients with Advanced or Metastatic Renal Cell Carcinoma (RCC) Details
IRB17-0565 Stadler, Walter A Phase II Study of TAK-228 in patients with previously treated metastatic renal cell carcinoma Details
CIRB16-1405 Stadler, Walter S1500: A Randomized, Phase II Efficacy Assessment of Multiple MET Kinase Inhibitors (Cabozantinib, Crizotinib, Savolitinib, and Sunitinib) in Metastatic Papillary Renal Carcinoma Details
CIRB15-1357 Luke, Jason EAY131: Molecular Analysis for Therapy Choice (MATCH) Details
Phase I
Study No PI Title
IRB18-0605 Sweis, Randy A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors Details
IRB15-1130 Chmura, Steven Phase I study of PD1 blockade by pembrolizumab with stereotactic body radiotherapy in advanced solid tumors Details
IRB14-1542 Liauw, Stanley A Pilot Study Of Stereotactic Body Radiotherapy (SBRT) In Oligometastatic Renal Cell Carcinoma Details
Others
Study No PI Title
IRB15-0519 Eggener, Scott Randomized, prospective evaluation of hemostatic agents in robotic-assisted laparoscopic partial nephrectomy. Details
11-0062 Liauw, Stanley Long Term Database Collection for Renal Cell Carcinoma
12278A Steinberg, Gary Clinical Urology Research Screening Protocol


Although our objective is to provide on updated listings of clinical trials, please note that a listing here does not guarantee that a trial is open or available to any specific patient. Additional trials may be available that are not listed. Complete information is available only from a treating physician.

Are you part of the research staff and cannot see your study listed here? Please contact the cancer center IT Team .